{"a":[{"_":"Menarini signs $771M deal to take Gan & Lee GLP-1 to European market ","$":{"href":"/biotech/menarini-group-signs-771m-deal-take-gan-lee-glp-1-european-market","hreflang":"en"}}]}

Summary

Menarini Group has signed a deal with Gan & Lee Pharmaceuticals to develop and commercialize the GLP-1 agonist bofanglutide in Europe, with an upfront payment of €62 million ($72 million).